Linaclotide for chronic constipation
Part of Digestive system clinical trials.
This study tests a medication called linaclotide to see how well it works and how safe it is for people with chronic constipation or IBS-C. You may take the medication and keep track of your bowel habits in a daily diary.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old.
- You have chronic constipation or irritable bowel syndrome with constipation (IBS-C) as diagnosed by a doctor.
- Your recent colonoscopy (within the last year) showed no problems.
- You are willing to keep a daily bowel diary and follow the study instructions.
- You have not had any of these: unexplained weight loss, bleeding from the rectum, anemia, or a family history of cancer.
- You have not had stomach or intestinal surgery (except appendix or hemorrhoid removal) and are not taking certain medications that affect your bowels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for children aged 4–16 who have long-term constipation that doesn't get better with standard laxatives. It uses a test called anorectal manometry to measure how well the muscles in the bottom work, which can help guide treatment.
This study tests a treatment that puts healthy bacteria into your gut along with prebiotics (food for good bacteria) to help with long-lasting constipation that hasn't improved with other treatments.
This trial tests if a medication called linaclotide (a pill that helps with constipation) can improve the bowel-cleaning process before a colonoscopy. It may make the preparation easier and more effective.
This study tests whether virtual reality (VR) plus linaclotide can improve symptoms and quality of life in adults with IBS-C (IBS with constipation). You may be asked to use VR and take a study medicine, while doctors check that your IBS diagnosis fits strict criteria.
This early-stage study tests whether a medication called linaclotide can help improve bowel function in people with cystic fibrosis. Researchers will use MRI scans and other tests to see how the medication affects your digestive system.
This study tests whether lubiprostone (Amitiza) can help people with slow-transit constipation. If you have few bowel movements and tests show that stool moves slowly through your colon, this treatment may help you go more regularly.
Hear when a new Chronic Constipation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.